EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Covidien's enterprise value is €37,966 Mil.
Covidien's EBITDA for the trailing twelve months (TTM) ended in Dec. 2014 was €2,051 Mil. Therefore, Covidien's EV-to-EBITDA for today is 18.51.
The historical rank and industry rank for Covidien's EV-to-EBITDA or its related term are showing as below:
FRA:6COP'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 0 Med: 0 Max: 18.44
Current: 18.44
During the past 13 years, the highest EV-to-EBITDA of Covidien was 18.44. The lowest was 0.00. And the median was 0.00.
FRA:6COP's EV-to-EBITDA is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 16.15
vs FRA:6COP: 18.44
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-05-07), Covidien's stock price is €94.50.
Covidien's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2014 was €2.976. Therefore, Covidien's PE Ratio for today is 31.75.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Covidien EV-to-EBITDA Historical Data
The historical data trend for Covidien's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Covidien's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Covidien's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Covidien's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Covidien's EV-to-EBITDA falls into.
Covidien EV-to-EBITDA Calculation
Covidien's EV-to-EBITDA for today is calculated as:
Covidien's current Enterprise Value is €37,966 Mil.
Covidien's EBITDA for the trailing twelve months (TTM) ended in Dec. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €2,051 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Covidien (FRA:6COP) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Covidien's share price for today is €94.50.
Covidien's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.976.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Covidien's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Covidien PLC formerly known as Covidien Ltd. was incorporated in Bermuda in 2000 as a wholly-owned subsidiary of Tyco International Ltd. In June 2009, Covidien plc announced that one of its subsidiaries has completed the acquisition of VNUS Medical Technologies, Inc. In September 2009, the Company completed the acquisition of Power Medical Interventions Inc. In November 2009, the Company completed the acquisition of Aspect Medical Systems Inc. The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. Its products are found in almost every hospital in the United States. Its mission is to create and deliver innovative healthcare solutions, developed in ethical collaboration with medical professionals. It operates through two segments: Medical Devices and Medical Supplies. The Medical Devices segment includes the development, manufacture and sale of endomechanical instruments, energy devices, soft tissue repair products, vascular products, oximetry and monitoring products, airway and ventilation products, and other medical products. The Medical Supplies segment includes the development, manufacture and sale of nursing care products, medical surgical products, SharpSafety products and original equipment manufacturer products. Competitors of Medical Devices segment include diversified healthcare companies, such as Johnson & Johnson, Boston Scientific, Baxter and C.R. Bard. Its Nursing Care products include: Curity and Kerlix and Medical Surgical products include: Medi-Trace. The Company holds more than 13,000 patents and have over 10,500 patent applications pending in the United States and in certain other countries that relate to aspects of the technology used in many of its products. The Company is subject to numerous federal, state and local environmental protection and health and safety laws and regulations both within and outside the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:6COP has been successfully added to your 